Fig. 1
From: The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
Taxonomic summaries of taxa present in >1% of samples (n = 162) for a cohort of 24 CF patients with chronic P. aeruginosa infection as a function of days from the initiation of AZLI treatment. Grey and black bars below plots represent samples pre- and post- the initiation of AZLI, respectively. Days from the initiation of AZLI are represented on the x-axis; red text = off AZLI, green = on AZLI, blue = unknown AZLI status. Patient ID, gender, and response status are listed on each bar plot. Samples on systemic antibiotics (asterisks). Analysis of the microbiome reveals unique profiles associated with each patient and varying abundance of P. aeruginosa over time